Clinical Trials Browser

Phase 1 × Interventional × ARQ 197 × Clear all

NCT01468922 2022-07-01

Pazopanib and ARQ 197 for Advanced Solid Tumors

Phase 1 Completed

32 enrolled 21 charts

Neoplasms, Sarcoma

NCT01149720 2019-02-12

Determination of the Relative Bioavailability of ARQ 197 Tablet Formulation With Capsule C Formulation as a Reference in Subjects With Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT01517399 2019-02-12

Drug-drug Interaction Study of Tivantinib (ARQ 197) With Omeprazole, S-warfarin, Caffeine, Midazolam, and Digoxin in Cancer Subjects

Phase 1 Completed

Neoplasms

NCT01699061 2019-02-12

Effect of Tivantinib on the QTC Interval in Cancer Subjects

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT02150733 2019-02-12

Pharmacokinetics of Tivantinib in Subjects With Advanced Solid Tumors and Hepatic Impairment

Phase 1 Completed

Neoplasms

NCT01654965 2018-04-03

Tivantinib and Topotecan Hydrochloride in Treating Patients With Advanced or Metastatic Solid Tumors

Phase 1 Completed

Adult Solid Neoplasm

NCT01749384 2017-10-12

Tivantinib and Bevacizumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

Phase 1 Completed

Solid Neoplasm

NCT01069757 2017-03-15

A Study of ARQ 197 in Combination With Erlotinib

Phase 1 Completed

Carcinoma, Non-Small-Cell Lung

NCT01251796 2017-03-15

A Study of ARQ 197 in Combination With Erlotinib

Phase 1 Completed

Carcinoma, Non-Small-Cell Lung

NCT01625156 2015-10-20

Tivantinib and Temsirolimus in Treating Patients With Solid Tumors That is Metastatic or Cannot be Removed by Surgery

Phase 1 Completed

Adult Solid Neoplasm

NCT01725191 2015-07-02

Tivantinib in Treating Younger Patients With Relapsed or Refractory Solid Tumors

Phase 1 Completed

Childhood Solid Neoplasm

NCT00827177 2014-01-24

Dose Escalation Study of ARQ 197 in Combination With Sorafenib in Adult Patients With Advanced Solid Tumors

Phase 1 Completed

BreastDermatologicGastrointestinalGenitourinaryThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Melanoma, Neoplasms

NCT00609921 2012-09-07

A Phase 1 Study of ARQ 197 in Patients With Solid Tumors

Phase 1 Completed

Neoplasms

NCT00612209 2012-07-23

ARQ 197

Phase 1 Completed

Neoplasms

NCT00612703 2012-07-23

A Phase 1 Study of ARQ 197 in Adult Patients With Advanced Solid Tumors

Phase 1 Completed

Neoplasms

NCT00874042 2012-07-23

Dose Escalation Study of ARQ 197 in Combination With Gemcitabine in Adult Patients With Advanced Solid Tumors

Phase 1 Completed

Neoplasms

NCT00802555 2012-07-12

Safety Study of ARQ 197 in Cirrhotic Patients With Hepatocellular Carcinoma (HCC)

Phase 1 Completed

Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular

NCT00302172 2009-08-26

ARQ 197 in Subjects With Metastatic Solid Tumors

Phase 1 Completed

Neoplasm Metastasis, Neoplasms